Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12217-12225
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12217
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12217
Figure 1 Study design.
The three groups were represented by: Mycophenolate (MMF), calcineurin inhibitor (CNI) and TOL. All patients had a minimal follow up of 6 years from LT at the enrollment and were followed with yearly liver biopsy for 6 years.
Figure 2 Mean fibrosis progression rate of the three groups in 6 years of follow up.
FPR: Fibrosis progression rate; CNI: Calcineurin inhibitors; MMF: Mycophenolate.
- Citation: Manzia TM, Angelico R, Ciano P, Mugweru J, Owusu K, Sforza D, Toti L, Tisone G. Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients. World J Gastroenterol 2014; 20(34): 12217-12225
- URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12217.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12217